Insider Shareholders with Direct Ownership of Bausch Health Companies Inc. (BHC)
This section provides a comprehensive overview of the insiders with direct ownership of Bausch Health Companies Inc. (BHC). You can find detailed information about the size and nature of each insider's ownership stake, as well as the latest updates on their holdings.
Bausch Health Companies Inc. Insider List
| Insider | Adquired | Disposed | Held | # of Trades | Last Transaction |
|---|---|---|---|---|---|
|
Joseph C Papa
Director |
1,073,854 | 446,151 | 1,427,568 $14 Million | 13 |
May 10, 2022
Reduced 2.31%
|
|
Thomas Appio
Chief Executive Officer |
1,411,678 | 243,640 | 1,354,673 $13.2 Million | 22 |
Aug 30, 2024
Reduced 1.07%
|
|
Tom George Vadaketh
EVP, Chief Financial Officer |
517,569 | 54,259 | 564,933 $5.53 Million | 5 |
Sep 05, 2023
Reduced 7.22%
|
|
Seana Carson
EVP, General Counsel |
537,829 | 171,201 | 435,198 $4.26 Million | 21 |
Sep 06, 2024
Reduced 2.98%
|
|
Paul Herendeen
EVP and CFO |
163,281 | 75,274 | 386,618 $3.78 Million | 4 |
Mar 10, 2021
Reduced 13.34%
|
|
Richard U De Schutter
Director |
79,978 | 0 | 373,407 $3.65 Million | 14 |
Mar 31, 2023
Added 0.97%
|
|
Jean Jacques Charhon
EVP, CFO |
298,838 | 0 | 298,838 $2.92 Million | 1 |
Aug 19, 2024
Added 50.0%
|
|
John Paulson
Director |
183,888 | 0 | 260,295 $2.55 Million | 21 |
Sep 30, 2024
Added 2.86%
|
|
William D. Humphries
President, Ortho-Dermatologics |
150,859 | 150,859 | 235,035 $2.3 Million | 8 |
Dec 04, 2020
Reduced 32.67%
|
|
Russel C Robertson
Director |
116,580 | 0 | 225,279 $2.2 Million | 18 |
Mar 29, 2024
Added 1.29%
|
|
Amy B Wechsler
Director |
117,402 | 11,037 | 207,094 $2.03 Million | 22 |
Sep 30, 2024
Added 0.4%
|
|
Robert N Power
Director |
106,597 | 0 | 200,376 $1.96 Million | 4 |
May 17, 2024
Added 15.0%
|
|
Sarah B Kavanagh
Director |
106,597 | 0 | 182,012 $1.78 Million | 4 |
May 17, 2024
Added 16.27%
|
|
Steven D Miller
Director |
174,777 | 0 | 174,877 $1.71 Million | 14 |
May 17, 2024
Added 16.82%
|
|
Christina Ackermann
EVP AND GENERAL COUNSEL |
216,175 | 178,131 | 162,240 $1.59 Million | 12 |
Mar 10, 2022
Reduced 0.51%
|
|
Thomas W. Ross Sr.
Director |
71,237 | 0 | 161,516 $1.58 Million | 3 |
May 19, 2023
Added 15.31%
|
|
Brett Icahn
Director |
152,671 | 0 | 152,671 $1.49 Million | 20 |
Sep 30, 2024
Added 2.59%
|
|
John S Barresi
SVP, Controller & CAO |
165,417 | 15,011 | 150,406 $1.47 Million | 10 |
Sep 05, 2024
Reduced 2.58%
|
|
Aimee J. Lenar
EVP, US Pharma |
144,352 | 0 | 144,352 $1.41 Million | 1 |
Jul 15, 2024
Added 50.0%
|
|
Argeris N Karabelas
Director |
42,032 | 0 | 123,715 $1.21 Million | 2 |
Jun 24, 2022
Added 21.75%
|
|
Sam Eldessouky
EVP & Chief Financial Officer |
70,579 | 32,176 | 119,455 $1.17 Million | 10 |
Mar 03, 2022
Reduced 1.03%
|
|
Robert Spurr
President, U.S. Businesses |
106,395 | 32,626 | 112,741 $1.1 Million | 17 |
May 10, 2022
Added 10.76%
|
|
Joseph F Gordon
Pres&Co-Head Bausch&Lomb/Int'l |
64,199 | 50,623 | 93,139 $910,899 | 11 |
Mar 08, 2022
Reduced 4.01%
|
|
Richard Mulligan
Director |
65,909 | 0 | 65,909 $644,590 | 3 |
May 19, 2023
Added 30.71%
|
|
Andrew C. Von Eschenbach
Director |
9,045 | 0 | 38,647 $377,967 | 2 |
Aug 05, 2021
Added 3.5%
|
|
Christian A Garcia
Director |
35,360 | 0 | 35,360 $345,820 | 1 |
May 17, 2024
Added 50.0%
|
|
Frank D. Lee
Director |
35,360 | 0 | 35,360 $345,820 | 1 |
May 17, 2024
Added 50.0%
|
|
Frederick Munsch
SVP, Controller and CAO |
4,576 | 3,313 | 22,435 $219,414 | 6 |
May 03, 2022
Reduced 3.22%
|
|
David Robert Hale
Director |
43,600 | 8,414 | 18,682 $182,709 | 7 |
Apr 30, 2021
Added 29.04%
|